Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Latest reported RCUS revenue for 2026-06-30 was $58.0M. Net income was -$219.0M. RCUS currently screens at market cap $885.2M.
Use this RCUS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the RCUS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the RCUS SEC filings page. Lician reads the product cache first so this HTML stays unique to Arcus Biosciences Inc even when a live quote feed is slow.
Latest cached year on this hub. Full RCUS income, balance, and cash tables.